𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rapid-onset dystonia–parkinsonism: Linkage to chromosome 19q13

✍ Scribed by Patricia L. Kramer; Mari Mineta; Christine Klein; Karla Schilling; Deborah De Leon; Martin R. Farlow; Xandra O. Breakefield; Susan B. Bressman; William B. Dobyns; Laurie J. Ozelius; Allison Brashear


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
162 KB
Volume
46
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


Rapid-onset dystonia-parkinsonism (RPD) is an autosomal dominant movement disorder characterized by sudden onset of persistent dystonia and parkinsonism, generally during adolescence or early adulthood. Symptoms evolve over hours or days, and generally stabilize within a few weeks, with slow or no progression. Other features include little or no response to L-dopa, and low levels of homovanillic acid in the central nervous system. Neuroimaging studies indicate no degeneration of dopaminergic nerve terminals in RDP, suggesting that this disorder results from a functional deficit, as in dystonia, rather than neuronal loss, as in Parkinson's disease. We studied 81 members of two midwestern US families with RDP, 16 of whom exhibited classic features of RDP. We found significant evidence for linkage in these two families to markers on chromosome 19q13, with the highest multipoint LOD score at D19S198 (z ‫؍‬ 5.77 at ‫؍‬ 0.0). The flanking markers D19S587 and D19S900 define a candidate region of approximately 8 cM. Although RDP itself is a rare condition, it is important because it has clinical and biochemical similarities to both Parkinson's disease and dystonia. Identification of the genetic defect in RDP holds promise for understanding the underlying disease processes of both of these more common diseases.


📜 SIMILAR VOLUMES


Rapid-onset dystonia–parkinsonism: A fou
✍ Jacek Zaremba; Hanna Mierzewska; Zofia Lysiak; Patricia Kramer; Laurie J. Ozeliu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

## Abstract Rapid‐onset dystonia–parkinsonism (RDP, __DYT12__, MIM 128235) is a rare autosomal dominant movement disorder characterized by abrupt onset of slow, dystonic movements and prominent bulbar features. Three families and 1 isolated case have been described in the literature, and linkage to

Variable phenotype of rapid-onset dyston
✍ Dr. A. Brashear; M. R. Farlow; I. J. Butler; E. J. Kasarskis; W. B. Dobyns 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 458 KB

## Abstract Rapid‐onset dystonia‐parkinsonism (RDP) is an autosomal dominant disorder characterized by the rapid onset of dystonic spasms and parkinsonism over a period of a few hours to weeks after their onset. We have seen two additional members of this previously reported family with RDP who pre

Sporadic rapid-onset dystonia–parkinsoni
✍ Daan J. Kamphuis; Hans Koelman; Andrew J. Lees; Marina A.J. Tijssen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB 👁 1 views

## Abstract We report on a 38‐year‐old patient with rapid‐onset dystonia–parkinsonism (RDP) with a missense mutation in the Na/K‐ATPase α3 subunit (ATP1A3). Asymmetrical parkinsonian symptoms evolved over a year. After a stable episode of another 2.5 years, overnight he developed oromandibular dyst

Suggestive linkage to chromosome 19 in a
✍ Aida M. Bertoli-Avella; Jose L. Giroud-Benitez; Vincenzo Bonifati; Eduardo Alvar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

## Abstract The identification of disease genes using family‐based approaches has provided important insights into the pathogenesis of Parkinson's disease (PD) demonstrating the importance of genetic studies on monogenic forms of the disease. We studied a large Cuban family with typical, late‐onset

Cerebrospinal fluid homovanillic acid le
✍ Dr Allison Brashear; Ian J. Butler; Keith Hyland; Martin R. Farlow; William B. D 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Rapid-onset dystonia-parkinsonism (RDP) is characterized by sudden onset over hours to days of dystonia, dysphagia, dysarthria, and parkinsonism. RDP has been reported by our group in two apparently unrelated families. We now report analysis of cerebrospinal fluid metabolites of dopamine, norepineph